sigmaplot for windows, version 12.0, build 12.2.0.45 (SYSTAT)
SYSTAT is a verified supplier 
90
Structured Review
SYSTAT
sigmaplot for windows, version 12.0, build 12.2.0.45
Sigmaplot For Windows, Version 12.0, Build 12.2.0.45, supplied by SYSTAT, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sigmaplot+for+windows%2C+version+12%2E0%2C+build+12%2E2%2E0%2E45/sigmaplot+software/pm30605381-166-0-8
Average 90 stars, based on 1 article reviews
Sigmaplot For Windows, Version 12.0, Build 12.2.0.45, supplied by SYSTAT, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sigmaplot+for+windows%2C+version+12%2E0%2C+build+12%2E2%2E0%2E45/sigmaplot+software/pm30605381-166-0-8
Average 90 stars, based on 1 article reviews
sigmaplot for windows, version 12.0, build 12.2.0.45 - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
other:Article Title: Substitution of mitoxantrone for doxorubicin in a multidrug chemotherapeutic protocol for first-line treatment of dogs with multicentric intermediate- to large-cell lymphoma. Article Snippet: 236 JAVMA | JAN 15, 2019 | VOL 254 | NO. 2 Lymphoma is the most common neoplastic disorder in dogs, representing 83% of hematopoietic tumors and 24% of all tumors in dogs.1 The current standard treatment for dogs with intermediateto large-cell lymphoma involves administration of a multiagent, CHOP-based protocol, yielding overall response rates of 85% to 95% and median survival times of 10 to 12 months.. This is an improvement when compared with results for a doxorubicin-free protocol consisting of cyclophosphamide, vincristine, and Substitution of mitoxantrone for doxorubicin in a multidrug chemotherapeutic protocol for first-line treatment of dogs with multicentric intermediateto large-cell lymphoma |